|

Peg IFN-α-2b Clinical Trials

3 actively recruiting trials

Top Sponsors

  • Beijing 302 Hospital2
  • First Affiliated Hospital Xi'an Jiaotong University1

Indications

  • Liver Disease3
  • Chronic Hepatitis b2
  • Hepatitis B Virus (HBV)1
  • Hepatitis B1
  • Hepatitis B, Chronic (CHB)1

Other3 trials

Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study
Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients
N/A
The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.